Company: SNSE
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0000950170-25-103101
Chunk: 1

Company: Sensei Biotherapeutics, Inc.
Filing Date: 2025-08-05
Form: 10-Q
Item: Item 1
Chunk 1
---
2025 and December 31, 2024; 1,261,290 and 1,258,940 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively

     —

     —

     Additional paid-in capital

     301,177

     300,451

     Accumulated deficit

     (273,852
     )

     (262,052
     )

     Accumulated other comprehensive loss

     (11
     )

     (13
     )

     Total stockholders’ equity

     27,314

     38,386

     Total liabilities and stockholders’ equity
      
     $
     31,783

     $
     45,361

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.